MAYOSAFE FORTE SOFTGEL CAPSULES

Product Description

MAYOSAFE FORTE SOFTGEL CAPSULES, powered by Bupropion 150mg, is a well-tolerated, prescription-grade medication widely used for smoking cessation support and depression management. This extended-release formula offers enhanced bioavailability and consistent therapeutic effects, making it a dependable choice for healthcare professionals.Formulated with high standards and manufactured in WHO-GMP certified facilities, MAYOSAFE FORTE is ideal for bulk procurement by pharmaceutical distributors, hospital pharmacies, and B2B healthcare buyers seeking a clinically trusted, fast-moving product in the neuropsychiatry segment.Key Benefits: Contains Bupropion 150mg effective in treating major depressive disorder (MDD) and nicotine addiction Non-sedative and well-suited for long-term use Enhanced patient adherence with softgel capsule format Manufactured with international quality standards Primary Applications: Smoking cessation aid Treatment of clinical depression and seasonal affective disorder (SAD) Used in mental health clinics and neuro care centers Why Distributors Choose MAYOSAFE FORTE: High demand neuropsychiatric product with proven market traction Attractive margins for B2B resellers and exporters Available in bulk packs for hospitals, clinics, and online pharmacies